Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2005 1
2012 1
2013 2
2014 2
2021 5
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19 : A Cohort Study.
Kip KE, McCreary EK, Collins K, Minnier TE, Snyder GM, Garrard W, McKibben JC, Yealy DM, Seymour CW, Huang DT, Bariola JR, Schmidhofer M, Wadas RJ, Angus DC, Kip PL, Marroquin OC. Kip KE, et al. Among authors: wadas rj. Ann Intern Med. 2023 Apr;176(4):496-504. doi: 10.7326/M22-1286. Epub 2023 Apr 4. Ann Intern Med. 2023. PMID: 37011399 Free PMC article. Clinical Trial.
Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days.
McCreary EK, Bariola JR, Minnier T, Wadas RJ, Shovel JA, Albin D, Marroquin OC, Schmidhofer M, Wisniewski MK, Nace DA, Sullivan C, Axe M, Meyers R, Khadem T, Garrard W, Collins K, Wells A, Bart RD, Linstrum K, Montgomery SK, Haidar G, Snyder GM, McVerry BJ, Seymour CW, Yealy DM, Huang DT, Angus DC. McCreary EK, et al. Among authors: wadas rj. Contemp Clin Trials. 2022 Feb;113:106652. doi: 10.1016/j.cct.2021.106652. Epub 2021 Dec 9. Contemp Clin Trials. 2022. PMID: 34896293 Free PMC article. Clinical Trial.
Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era.
McCreary EK, Kip KE, Collins K, Minnier TE, Snyder GM, Steiner A, Meyers R, Borneman T, Adam M, Thurau L, Yealy DM, Huang DT, Bariola JR, Schmidhofer M, Wadas RJ, Angus DC, Kip PL, Marroquin OC. McCreary EK, et al. Among authors: wadas rj. Open Forum Infect Dis. 2022 Oct 1;9(10):ofac517. doi: 10.1093/ofid/ofac517. eCollection 2022 Oct. Open Forum Infect Dis. 2022. PMID: 36324319 Free PMC article.
The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial.
McCreary EK, Bariola JR, Minnier TE, Wadas RJ, Shovel JA, Albin D, Marroquin OC, Kip KE, Collins K, Schmidhofer M, Wisniewski MK, Nace DA, Sullivan C, Axe M, Meyers R, Weissman A, Garrard W, Peck-Palmer OM, Wells A, Bart RD, Yang A, Berry LR, Berry S, Crawford AM, McGlothlin A, Khadem T, Linstrum K, Montgomery SK, Ricketts D, Kennedy JN, Pidro CJ, Haidar G, Snyder GM, McVerry BJ, Yealy DM, Angus DC, Nakayama A, Zapf RL, Kip PL, Seymour CW, Huang DT. McCreary EK, et al. Among authors: wadas rj. Contemp Clin Trials. 2022 Aug;119:106822. doi: 10.1016/j.cct.2022.106822. Epub 2022 Jun 11. Contemp Clin Trials. 2022. PMID: 35697146 Free PMC article. Clinical Trial.
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19.
McCreary EK, Bariola JR, Wadas RJ, Shovel JA, Wisniewski MK, Adam M, Albin D, Minnier T, Schmidhofer M, Meyers R, Marroquin OC, Collins K, Garrard W, Berry LR, Berry S, Crawford AM, McGlothlin A, Linstrum K, Nakayama A, Montgomery SK, Snyder GM, Yealy DM, Angus DC, Kip PL, Seymour CW, Huang DT, Kip KE. McCreary EK, et al. Among authors: wadas rj. JAMA Netw Open. 2022 Apr 1;5(4):e226920. doi: 10.1001/jamanetworkopen.2022.6920. JAMA Netw Open. 2022. PMID: 35412625 Free PMC article.
Emergency department implementation of monoclonal antibody infusion for the treatment of coronavirus disease 2019: A template for rapid deployment.
Woltemate TJ, Wadas RJ, McCreary EK, Bariola R, Minnier T, Marroquin OC, Schmidhofer M, Albin D, Angus DC, Yealy DM. Woltemate TJ, et al. Among authors: wadas rj. J Am Coll Emerg Physicians Open. 2021 Sep 17;2(5):e12550. doi: 10.1002/emp2.12550. eCollection 2021 Oct. J Am Coll Emerg Physicians Open. 2021. PMID: 34568870 Free PMC article.
Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Bariola JR, McCreary EK, Wadas RJ, Kip KE, Marroquin OC, Minnier T, Koscumb S, Collins K, Schmidhofer M, Shovel JA, Wisniewski MK, Sullivan C, Yealy DM, Nace DA, Huang DT, Haidar G, Khadem T, Linstrum K, Seymour CW, Montgomery SK, Angus DC, Snyder GM. Bariola JR, et al. Among authors: wadas rj. Open Forum Infect Dis. 2021 May 17;8(7):ofab254. doi: 10.1093/ofid/ofab254. eCollection 2021 Jul. Open Forum Infect Dis. 2021. PMID: 34250192 Free PMC article.
A comparative assessment of adverse event classification in the out-of-hospital setting.
Patterson PD, Lave JR, Weaver MD, Guyette FX, Arnold RM, Martin-Gill C, Rittenberger JC, Krackhardt D, Mosesso VN, Roth RN, Wadas RJ, Yealy DM. Patterson PD, et al. Among authors: wadas rj. Prehosp Emerg Care. 2014 Oct-Dec;18(4):495-504. doi: 10.3109/10903127.2014.916022. Epub 2014 May 30. Prehosp Emerg Care. 2014. PMID: 24878451 Free PMC article.
15 results